Advertisement
Advertisement
GH
Guardant Health, Inc. Common Stock
114.04
USDSponsored
+3.63
+3.29%
Jan 30, 16:00 UTC -5
Closed
Pre-Market
113.97
-0.07
-0.06%
GH Earnings Reports
Positive Surprise Ratio
GH beat 13 of 29 last estimates.
45%
Next Report
Date of Next Report
Feb 19, 2026
Estimate for Q4 25 (Revenue/ EPS)
$277.19M
/-$0.72
Implied change from Q3 25 (Revenue/ EPS)
+4.52%
/-2.70%
Implied change from Q4 24 (Revenue/ EPS)
+37.35%
/-20.00%
Guardant Health, Inc. Common Stock earnings per share and revenue
On Oct 29, 2025, GH reported earnings of -0.74 USD per share (EPS) for Q3 25, missing the estimate of -0.72 USD, resulting in a -2.27% surprise. Revenue reached 265.20 million, compared to an expected 242.76 million, with a 9.24% difference. The market reacted with a +27.87% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 25 analysts forecast an EPS of -0.72 USD, with revenue projected to reach 277.19 million USD, implying an decrease of -2.70% EPS, and increase of 4.52% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Regeneron Pharmaceuticals Inc
Report Date
Jan 30, 2026 For Q4 25
Estimate
$10.84
Actual
$11.44
Surprise
+5.52%
Twist Bioscience Corporation Common Stock
Report Date
Feb 02, 2026 For Q1 26
Estimate
-$0.43
Actual
-$0.50
Surprise
-14.00%
Nurix Therapeutics, Inc. Common stock
Report Date
Jan 28, 2026 For Q4 25
Estimate
-$0.88
Actual
-$0.82
Surprise
+7.66%
FAQ
What were Guardant Health, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Guardant Health, Inc. Common Stock reported EPS of -$0.74, missing estimates by -2.27%, and revenue of $265.20M, 9.24% above expectations.
How did the market react to Guardant Health, Inc. Common Stock's Q3 2025 earnings?
The stock price moved up 27.87%, changed from $72.27 before the earnings release to $92.41 the day after.
When is Guardant Health, Inc. Common Stock expected to report next?
The next earning report is scheduled for Feb 19, 2026.
What are the forecasts for Guardant Health, Inc. Common Stock's next earnings report?
Based on 25
analysts, Guardant Health, Inc. Common Stock is expected to report EPS of -$0.72 and revenue of $277.19M for Q4 2025.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement